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This study was designed to evaluate the antimycobacterial, antibacterial and antifungal activities of the methanol extract from the stem bark of
Thecacoris annobonae Pax & K. Hoffm, that of aristolochic acid I (1) and other isolated compounds. The microplate alamar blue assay (MABA)
and the broth microdilution method were used to determine the minimal inhibitory concentration (MIC) and minimal microbicidal concentration
(MMC) of the above samples. The H+-ATPase-mediated proton pumping assay was used to evaluate a possible mechanism of action for both the
methanol extract and aristolochic acid I. The results of the MIC determinations showed that the methanol extract and aristolochic acid I prevent
the growth of all studied organisms. The results obtained in this study also showed that the methanol extract as well as aristolochic acid I inhibited
the H+-ATPase activity. The overall results provided evidence that the methanol extract of T. annobonae might be a potential source of new
antimicrobial drug against tuberculosis, and some bacterial and fungal diseases, but should be consumed with caution, bearing in mind that the
main active component, aristolochic acid I is a potentially toxic compound.
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Infectious diseases are serious health problems worldwide.
Tuberculosis (TB) infection, caused by Mycobacterium species
remains one of the most important modifiable infectious human
diseases in the developing world with more than 2 billion
people being infected (McGaw et al., 2008). World statistics
of TB reached a ceiling of estimated 9.2 million new cases
and 1.7 million deaths in 2006 (McGaw et al., 2008). TB is
widespread in poor countries with the highest incidence of the
disease (more than 80% of cases) occurring in Asia and Africa
(Zager and McNerney, 2008). The annual incidence of the
disease indicates a rate of over 600 cases per 100,000 reported⁎ Corresponding author. Tel.: +237 77 355927; fax: +237 22 226018.
E-mail address: kuetevictor@yahoo.fr (V. Kuete).
0254-6299/$ - see front matter © 2010 SAAB. Published by Elsevier B.V. All righ
doi:10.1016/j.sajb.2010.04.003in many sub-Saharan Africa countries (Corbett et al., 2006)
with the persistent increase attributed to the acquired immune
deficiency syndrome pandemic combined with inadequate
healthcare systems (Zager and McNerney, 2008). Typhoid
fever (TF) is a more classical systemic infection caused by the
typhoid bacillus, Salmonella enterica serovar Typhi, the most
common cause of enteric fever, which also includes paratyphoid
fever caused by S. paratyphi A, B and C. With an estimated
16–33 million cases resulting in 500,000 to 600,000 deaths
annually in endemic areas, the WHO (2009) identifies typhoid
as a serious public health problem. The true burden of TF in
developing countries is difficult to estimate. According to recent
estimates, 22 million cases occur each year causing 216,000
deaths, predominantly in school-age children and young adults
(Crump et al., 2004). Asia, with 274 cases per 100,000 persons
has the highest incidence of TF cases worldwide, especially ints reserved.
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followed by sub-Saharan Africa and Latin America with 50
cases per 100,000 persons. In an urban slum in Dhaka, incidence
of TF was found to be 390/100,000 persons (Brooks et al., 2005).
Staphylococcus aureus can cause a range of illnesses from minor
skin infections to life-threatening diseases such as pneumonia,
meningitis, osteomyelitis, endocarditis, toxic shock syndrome, and
septicemia (Carbonnelle et al., 1987). Pseudomonas aeruginosa
is a highly relevant opportunistic pathogen and one of its most
worrisome characteristics is its low antibiotic susceptibly (Sleigh
and Timbury, 1998). Also, Candida species are the predominant
pathogens causing invasive disease in intensive care, invasive
fungal infections being of increasing relevance for severely ill and
immuno-compromised patients (Presterl et al., 2009), with up to
50% mortality (Wenzel, 1995).
Due to the permanent resistance of the microorganisms to
available drugs, continuous search for new antimicrobials is a
scientific challenge. Natural products continue to play a most
significant role in the drug discovery and development process
(Newman and Cragg, 2007), and plants are recognized as a
useful sources of highly active antimicrobial metabolites
(Gibbons, 2005; Pauli et al., 2005). In our continuous search
of antimicrobial agents from natural sources, this study was
designed to assess the antimycobacterial, antibacterial and
antifungal activities of Thecacoris annobonae Pax & K. Hoffm
(Euphorbiaceae). T. annobonae is a tree found in Cameroon and
Equatorial Guinea. Its natural habitat is subtropical or tropical
moist lowland forests and was listed as an endangered species
(Cheek, 2004). Though few medicinal properties have been
reported on the genus Thecacoris, T. batesii is used as a
purgative and antirheumatic remedy in the traditional medicine
in Cameroon (Ngadjui and Abegaz, 2003; Ngadjui et al., 2007).
2. Material and methods
2.1. Plantmaterial, instruments, solvents, extraction and isolation
The stem bark of T. annobonae was collected in March 2005
at Kumba, South-West (Cameroon) and identified at the
Cameroon National Herbarium, where a voucher specimen is
deposited (Ref. No 38569/HNC).
Air dried powdered stem bark of T. annobonae (2.8 kg) was
extracted with MeOH at room temperature for 48 h. After
removing the solvent by evaporation under reduced pressure,
the crude extract (100.2 g) was chromatographed on silica gel
using hexane/ethyl acetate in increasing polarity (pure hexane;
hexane/ethyl acetate 7.5/2.5; hexane/ethyl acetate 5:5; hexane/
ethyl acetate 2.5/7.5; pure ethyl acetate). One hundred and
fifteen fractions were collected and pooled on the basis of
analytical thin layer chromatography in three main fractions, A
(fraction 1 to 36); B (37–88); and C (89–115).
Fraction A (5.0 g) was column chromatographed using silica
gel 60 and eluted with CH2Cl2–MeOH (1:3). Thirty-two sub-
fractions of 100 ml each were collected and subtractions 13–26
were purified by using column chromatography on Sephadex
LH-20 with CH2Cl2–MeOH (1:1) as eluent to afford aris-
tolochic acid I C17H11NO7 [1; yellow amorphous powder,4.7 mg; Rf: 0.3 (CH2Cl2/3%MeOH); m/z: 341] (Priestap, 1989;
Arlt et al., 2002) and aristolochic acid I methyl ester C18H13NO7
[2; Yellow amorphous powder; Rf: 0.4 (CH2Cl2/3%MeOH);
9.0 mg; m/z: 355] (Arlt et al., 2002).
Fraction B (13.0 g) was chromatographed on silica gel and
eluted with a mixture of hexane/ethyl acetate in increasing
polarity. Fraction eluted hexane/ethyl acetate 40:60 yielded
vanillic acid C8H8O4 [3, Brown amorphous powder; 6.7 mg;
Rf=0.3 (CH2Cl2/5% MeOH); m/z: 168] (Fang et al., 2008) and
4-acetoxy vanillic acid C10H10O5 [4, amorphous powder;
10.0 mg; Rf: 0.5 (CH2Cl2/5% MeOH); m/z: 209] (Li and
Huang, 2000).
Fraction C (17.0 g) was chromatographed on silica gel and
eluted using hexane/ethyl acetate. A total of 50 fractions of
300 ml each were collected and combined on the basis of TLC
analysis leading to two main series (I and II). Series I (1.5 g)
[fractions 1–37] was column chromatographed on silica gel and
eluted with CH2Cl2–MeOH (3:1) to yield friedelin C30H50O [6,
White powder; Rf: 0.7 (CH2Cl2); 3.9 mg; m.p.: 247–249 °C;m/z:
426] (Ageta and Arai, 1990). Series II (0.9 g) [fractions 38–50]
eluted with CH2Cl2–MeOH (7:9) yielded friedelin-3β-ol
C30H52O [5, White powder; Rf: 0.6 (CH2Cl2); 5.4 mg; m.p.:
229–231 °C; m/z: 428] (Fun et al., 2007; Ng'ang'a et al., 2008).
2.2. General experimental instruments and procedure
Nuclear magnetic resonance (NMR) spectra were measured
on Varian Unity 300 (300.145 MHz) and Varian Inova 500
(499.876 MHz) spectrometers. ESI mass spectra were recorded
on A Finnigan LCQ with quaternary pump Rheos 4000 (Flux
Instrument). ESI HR mass spectra were recorded on A Bruker
FTICR 4.7 T mass spectrometer. EI mass spectra were recorded
on a Finnigan MAT 95 spectrometer (70 eV) with perfluor-
okerosene as reference substance for HREI-MS. IR spectra were
recorded on a Perkin-Elmer 1600 Series FT-IR spectrometer
from films. Melting and decomposition points were measured
with an Electrothermal (Yanaco, Tokyo-Japan) melting point
apparatus and were not corrected.
2.3. Microbial strains and culture media
The test organisms included Mycobacteria namely Mycobac-
terium smegmatis ATCC 700084, drug-susceptible strain of
Mycobacterium tuberculosis H37Rv ATCC 27294 (America
Type Culture Collection, Rockville, MD, USA), two clinical
strains, M. tuberculosis MTCS1, and M. tuberculosis MTCS2,
Gram-positive bacteria (B) including a methicillin-resistant
S. aureus B845, Streptococcus faecalis B 846, Bacillus cereus
B864, Gram-negative bacteria namely β-lactamase positive
(βL+) Escherichia coli B831, ampicillin-resistant Klebsiella
pneumoniae B837, carbenicillin-resistant P. aeruginosa B832,
chloramphenicol-resistant Salmonella typhi B839, chloramphen-
icol-resistantCitrobacter freundiiB828 and two fungi (F) namely
Candida albicans F702 and Microsporum audouinii F712. The
clinical isolates were obtained from Yaoundé General Hospital
(Cameroon). Their identifications were confirmed (and they were
encoded) before use at the Laboratory of Applied Microbiology
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University of Yaoundé I). This was followed by culturing on
the specific media and biochemical test using API system as
previously reported (Mbaveng et al., 2008). M. smegmatis was
cultured onMiddlebrook 7H11 agar and allowed to grow for 24 h.
M. tuberculosis was plated on Löwenstein-Jensen medium and
allowed to grow for 3–4 weeks at 37 °C. Middlebrook 7H9 broth
was used to determine the MIC and MMC values of the test
samples on M. smegmatis and M. tuberculosis. Nutrient Agar
(NA) was used for other bacteria. Sabouraud Glucose Agar was
used for the activation of fungi. Mueller Hinton broth (MHB) was
used to determine theMIC andMMCof all samples against fungi,
Gram-positive and Gram-negative bacteria.
2.4. Reference antibiotics
Ciprofloxacin and isoniazid (INH) (Sigma) were used as
reference antibiotics (RA) forM. smegmatis andM. tuberculosis
respectively. Nystatin (Sigma) and gentamycin (Sigma) were
used as RA respectively against fungi and other bacteria.
2.5. Microplate alamar blue assay
The activity of all samples againstM. tuberculosis strains was
tested using the MABA (Jimenez-Arellanes et al., 2003). Briefly,
each of the aboveM. tuberculosis strains was cultured at 37 °C in
Middlebrook 7H9 broth supplemented with 0.2% glycerol and
10% Oleic Acid–Albumin–Dextrose–Catalase (Sigma) until
logarithmic growth was reached. About 6×106 CFU/ml inocu-
lum of M. tuberculosis was then added to the two fold serially
diluted samples. The final concentration of DMSO in all assays
was 2.5% or less and this dilution also served as solvent control.
The samples were assayed in triplicate. All tests were carried out
in sterile flat-bottomed 96-well microplates. Each microplate was
incubated for 5 days at 37 °C in a 5%CO2 atmosphere in a sealed
plastic CO2-permeable bag. After 5 days of incubation, 32 µl of a
mixture of freshly prepared alamar blue solution and 20% sterile
Tween-80 (Sigma) 1:1 v/v were added to one growth-control
well. The microplates were incubated again at 37 °C for 24 h. If a
colour shift from blue to pink was observed in the growth-control
sample, 32 µl of alamar blue solution was added to each of the
remaining wells, and the microplate was further incubated for
24 h. A well-defined pink colour was interpreted as positive
bacterial growth, whereas a blue colour indicated an absence of
growth. The MIC corresponded to the greatest dilution of sample
extract in which the colour shift from blue to pink was not
observed.
Samples with recorded MIC values following MABA were
assayed for their mycobactericidal effect (Jimenez-Arellanes
et al., 2003). Briefly, 5 µl of the undeveloped mycobacterial
suspensions were transferred from the former to a newmicroplate
that contained 195 µl of fresh culture medium per well. Three
wells were inoculated with 100 µl of fresh inoculum as for
MABA and three more wells were incubated with 200 µl of
culture medium only, as negative controls. The microplates were
incubated and developed with Alamar Blue as for MABA. The
MMC corresponded to the minimum sample concentration thatdid not cause a colour shift in cultures re-incubated in fresh
medium.
2.6. XTT colourimetric assay
The MIC determinations on M. smegmatis, fungi, Gram-
positive and negative bacteria were conducted using rapid XTT
colorimetric assay according to Pettit et al. (2005) and Eloff
(1998). The test sample and RA were first of all dissolved in
DMSO/MHB or DMSO/7H9 broth. The final concentration of
DMSO was lower than 2.5% and does not affect the microbial
growth. The solution obtained was then added to 7H9 broth
(M. smegmatis) or MHB (other organisms), and serially diluted
two fold (in a 96-well microplate). 100 µl of inoculum
1.5×106 CFU/ml prepared in appropriate broth was then added.
The plates were covered with a sterile plate sealer, then agitated to
mix the contents of the wells using a plate shaker and incubated at
30 °C for 48 h (M. audouinii) or 37 °C for 18 h (other organisms).
The assay was repeated thrice. Wells containing adequate broth,
100 µl of inoculum and DMSO to a final concentration of 2.5%
served as negative control. TheMIC of samples was detected after
18 h incubation at 37 °C, following addition (40 µl) of 0.2 mg/ml
p-iodonitrotetrazolium violet (INT) and incubation at 37 °C for
30 min.Viable bacteria reduced the yellowdye to a pink.MICwas
defined as the lowest sample concentration that inhibited this
change. The MMC was determined by adding 50 µl aliquots of
the preparations, which did not show any growth after incuba-
tion during MIC assays, to 150 µl of adequate broth. These
preparations were incubated at 37 °C for 48 h. The MMC was
regarded as the lowest concentration of extract, which did not
produce a colour change after addition of INT asmentioned above.
2.7. Effects of the methanol extract and aristolochic acid I on
H+-ATPase-mediated proton pumping
The proton-pumping activities of E. coli were determined
monitoring glucose-induced acidification of the external medium
by measuring the pH with an electrode (Manavathu et al., 2001).
Briefly, 50 ml cultures of E. coli were grown in MHB to late log
phase (absorbance of 5 at 590 nm wavelength). The resulting
cultures were centrifuged at 3500 g for 10 min. The pellet was
washed oncewith distilledwater, then oncewith 50 mMKCl, and
re-suspended in 50 ml of 50 mM KCl. The cells suspension was
incubated at 4 °C overnight (18 h) for glucose starvation, then
centrifuged and diluted to the absorbance of 8 (at 590 nm) in
1.8 ml of reaction medium (a spectrophotometer curve of 3 ml)
containing 50 mM KCl, methanol extract of T. annobonae and
compound 1 (at MIC and MIC/10), and all adjusted to pH 6.4.
After 10 min pre-incubation at 37 °C, medium acidification
was initiated after addition of glucose 20% (0.2 ml). The pH
was measured after every 10 min for 1 h. DMSO 2.5% was used
instead of compound 1 as the control.
3. Results
The structures of the isolated compounds were established
using spectroscopic analysis. The compounds isolated from the
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aristolochic acid I methyl ester (2), vanillic acid (3), 4-acetoxy
vanillic acid (4), friedelin-3β-ol (5) and friedelin (6).
The results of the MIC determinations (Table 1) showed that
the methanol extract and compound 1 were able to prevent the
growth of all studied organisms, including mycobacteria, fungi,
Gram-positive and Gram-negative bacteria, within the concen-
tration range of 9.76 to 312.50 µg/ml. Other compounds showed
selective activity, with their inhibitory effects being noted on
7 of the 14 (50%), 6/14 (42.9%), 5/14 (35.7%), 3/14 (21.4%)
studied organisms respectively for compounds 5, 4, 2 and 3. The
lowest MIC value for the methanol extract (19.53 µg/ml) was
obtained on sensitiveM. tuberculosis H37Rv strain. The lowest
value for individual compounds (9.76 µg/ml) was recorded with
compound 1 on M. tuberculosis H37Rv, Bacillus cereus and
P. aeruginosa. Results of MMC determinations (Table 2) also
showed good activities for both crude extract and compound 1.
MMC values not greater than 312.50 µg/ml were recorded on
13/14 (92.9%) and 12/14 (85.7%) studied microorganisms
respectively for compound 1 and the crude extract. The results
illustrated in Fig. 2 showed that compound 1 was able to totally
inhibit the H+-ATPase activity when tested at the MIC values.
An important, but not total inhibitory activity was also noted at
with the methanol extract MIC, meanwhile lower concentrations
were less active. However, the inhibitory effect was still
observable up to MIC/10.Fig. 1. Chemical structures of compounds isol4. Discussion
The compounds isolated from T. annobonae were two
alkaloids (1–2), two phenolic acids (3–4), and two terpenoids
(5–6).Many compounds belonging to these secondarymetabolite
classes have been reported for their antimicrobial activities
(Bruneton, 1999; Cowan, 1999). The antimicrobial activity of
friedelin (6) on fungi and bacteria has recently been reported
(Kuete et al., 2007). Therefore this compound was not tested
in this study. The antimicrobial activity of vanillic acid against
Listeria monocytogenes, L. innocua, L. grayi, and L. seeligeriwas
reported (Delaquis et al., 2005). Contrary to previously
documented data on Listeria sp, vanillic acid (3) and its derivative
(4) showed only very weak activity on the mycobacteria, fungi
and other bacterial species observed in this study. To the best of
our knowledge, the antimicrobial activity of T. annobonae as well
as that of aristolochic acid I is being reported for the first time.
This study identifies aristolochic acid I as the main antimicrobial
component of this plant. Only a few pharmacological activities
on the genus Thecacoris are documented. This study therefore
provides important baseline information for the antimicrobial
activity of this genus. However, it has been documented that
aristolochic acid, a rodent carcinogen, also exhibiting high
nephrotoxicity (http://www.cfsan.fda.gov). Despite these well-
documented dangers, aristolochic acid is still sometimes used as
herbal remedy for weight loss (http://www.cfsan.fda.gov).ated from the stem bark of T. annobonae.
Table 1
MIC (µg/ml) of the methanol extract and compounds isolated (1–5) from T. annobonae and reference drugs on the studied microbial species.
Microbial species Tested samples
Methanol
extract
Isolated compounds RA*
1 2 3 4 5
Mycobacteria
Mycobacterium smegmatis 39.06 19.53 – – – 312.50 0.61
Mycobacterium tuberculosis H37Rv 19.53 9.76 – – – – 0.31
Mycobacterium tuberculosis MTCS1 78.12 39.06 – – – – 78.12
M. tuberculosis MTCS2 78.12 19.53 – – – – 0.61
Gram-positive bacteria
Bacillus cereus 39.06 9.76 312.50 312.50 312.50 156.25 9.76
Staphylococcus aureus 312.50 156.25 – – – – 9.76
Streptococcus faecalis 312.50 78.12 – – – 312.50 9.76
Gram-negative bacteria
Citrobacter freundii 312.50 156.25 – – – – 19.53
Escherichia coli 39.06 19.53 156.25 156.25 156.25 39.06 9.76
Pseudomonas aeruginosa 39.06 9.76 156.25 156.25 156.25 78.12 19.53
Klebsiella pneumoniae 39.06 19.53 312.50 – 156.25 78.12 78.12
Salmonella typhi 78.12 19.53 312.50 – 156.25 156.25 39.06
Fungi
Candida albicans 312.50 78.12 – – 156.25 – 39.06
Microsporum audouinii 312.50 156.25 – – – – 39.06
*RA: reference antibiotics (ciprofloxacin for M. smegmatis, isoniazid for M. tuberculosis, gentamicin for other bacteria, nystatin for fungi).
(–): MICN312.50.
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are not more than four folds their corresponding MICs. This
proves that the killing effects could be expected on the sensitive
strains (Mims et al., 1993). It is also important to note that
for antimicrobial activity, MIC value of 100 µg/ml is considered
significant for plant extracts (Borges-Argáez et al., 2007). The
MIC values lower than this threshold value (100 µg/ml) wereTable 2
MMC (µg/ml) of the methanol extract and compounds isolated (1–5) from T. anno
Microbial species Tested samples
Methanol
extract
Isolated comp
1
Mycobacteria
Mycobacterium smegmatis 78.12 39.06
Mycobacterium tuberculosis H37Rv 39.06 19.53
Mycobacterium tuberculosis MTCS1 156.25 78.12
M. tuberculosis MTCS2 312.50 39.06
Gram-positive bacteria
Bacillus cereus 78.12 19.53
Staphylococcus aureus – 312.50
Streptococcus faecalis 312.50 156.25
Gram-negative bacteria
Citrobacter freundii 312.50 –
Escherichia coli 78.12 39.06
Pseudomonas aeruginosa 156.25 19.53
Klebsiella pneumoniae 156.25 78.12
Salmonella typhi 156.25 39.06
Fungi
Candida albicans 312.50 312.50
Microsporum audouinii – 312.50
*RA: reference antibiotics (ciprofloxacin forM. smegmatis, isoniazid forM. tuberculo
was greater than 312.25 µg/ml.
(–): MMCN312.50.obtained on 9 of the studied microbial species (64.3%) showing
that T. annobonae extract is a potential candidate for future drug
development from a natural source. The results obtained with
aristolochic acid I (1) are significant, as some of the recorded
MIC values were lower than that of the reference drugs on many
tested organisms (Table 1). This explains why we focused on
this compound.bonae and reference drugs on the studied microbial species.
ounds RA*
2 3 4 5
nd nd nd – 1.22
nd nd nd nd 0.61
nd nd nd nd 156.25
nd nd nd nd 1.22
312.50 – 312.50 – 19.53
nd nd nd nd 19.53
nd nd nd – 19.53
nd nd nd nd 39.06
312.50 312.50 312.50 156.25 19.53
– 312.50 – – 39.06
– nd – – 156.25
312.50 nd 312.50 – 78.12
nd nd – nd 78.12
nd nd nd nd 78.12
sis, gentamicin for other bacteria, nystatin for fungi); nd: not determined as MIC
Fig. 2. Effect of the methanol extract (ME) of T. cf. annobonae and aristolochic
acid I (1) on the proton pumping of E. coli at MIC and MIC/10.
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extract and aristolochic acid I as observed in the colony count
assay also highlighted the anti-infective potency of this plant. This
confirmed the killing effect of this compound as well as that
of the methanol extract on the studied microbial species. When
investigating one of the possible mechanisms of action of the
methanol extract and compound 1, we have evaluated its capacity
to inhibit E. coliH+-ATPase-mediated proton pumping. It is well
known that bacteria are viable in a wide range of pH (1–11) and
that the bacterial cytoplasmic pH is kept near neutral (Padan et al.,
1981). It is also generally accepted that bacterial cytoplasmic pH
is regulated by various cation transport systems (Padan et al.,
1981). Some data suggests that in E. coli, cytoplasmic pH is
regulated by proton extrusion via the respiratory chain and
potassium influx at acid pH, and cation/proton antiporter
regulates the pH in alkaline states (Kobayashi, 1985). The data
obtained in this experiment therefore indicated that inhibition
of the H+-ATPase could be one of the possible antimicrobial
mechanisms of action of the methanol extract. That effect might
be due predominantly to the presence of compound 1. Other
mechanisms such as DNA interaction of this compound are to
be investigated. In fact, many alkaloid compounds are known
to exhibit their antimicrobial activity through their ability to
intercalate with DNA (Phillipson and O'Neill, 1987). It should be
noted that aristolochic acid, one of the active components
of this plant, was documented for its carcinogenicity, its high
nephrotoxicity and may be a causative agent in Balkan neph-
ropathy (Cosyns, 2003; Poon et al., 2007). However, the amount
in the plants extract was very low, explaining why this compound
was generally more active than the crude extract, as it appeared to
be one of its main bioactive components.
The data reported herein are very important, taking into
account the medical importance of the studied microorganisms,
and that this plant is consumed traditionally as anti-infective
remedy, without taking into account the presence of health-
compromising components such as aristolochic acid I. Hence, the
overall results of the present investigation provided evidence that
the crude extract T. annobonae could serve as an antimicrobial
drug but should be taken with caution, bearing in mind that
aristolochic acid I, a potentially nephrotoxic and carcinogenic
compound, is the main active component.Acknowledgements
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